Putting the Benefits of Percutaneous Coronary Revascularization into Perspective: from Trials to Guidelines

Overview

Journal Curr Cardiol Rep

Publisher Current Science

Specialty Cardiology & Vascular Diseases

Date 2008 Aug 22

PMID 18715536

Authors

Kamal Sharma

Mark J Eisenberg

Affiliations

Soon will be listed here.

Abstract

Prompt delivery of percutaneous coronary revascularization in the acute setting has been shown to decrease mortality, length of hospitalization, and patient recovery time. However, its routine use in stable coronary disease is less validated, especially in the absence of adequate medical treatment. Several studies have looked into the benefits of percutaneous coronary revascularization. Based on these studies, many clinical guidelines have been developed to aid in decision making. In this article, we outline the benefits and reality of percutaneous coronary revascularization. We explore the major trials and use the latest clinical guidelines as a framework for our discussion on the applicability of this procedure in the setting of acute coronary syndromes and stable coronary disease.

References

Abbate A, Biondi-Zoccai G, Appleton D, Erne P, Schoenenberger A, Lipinski M . Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2008; 51(9):956-64. DOI: 10.1016/j.jacc.2007.11.062. View

Brodie B, Hansen C, Stuckey T, Richter S, Versteeg D, Gupta N . Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms. J Am Coll Cardiol. 2006; 47(2):289-95. DOI: 10.1016/j.jacc.2005.08.065. View

Keeley E, Hillis L . Primary PCI for myocardial infarction with ST-segment elevation. N Engl J Med. 2007; 356(1):47-54. DOI: 10.1056/NEJMct063503. View

Antman E, Anbe D, Armstrong P, Bates E, Green L, Hand M . ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise.... J Am Coll Cardiol. 2004; 44(3):671-719. DOI: 10.1016/j.jacc.2004.07.002. View

Wijeysundera H, Vijayaraghavan R, Nallamothu B, Foody J, Krumholz H, Phillips C . Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials. J Am Coll Cardiol. 2007; 49(4):422-30. DOI: 10.1016/j.jacc.2006.09.033. View

Herrmann H . Transfer for primary angioplasty: the importance of time. Circulation. 2005; 111(6):718-20. DOI: 10.1161/01.CIR.0000156406.52178.C5. View

Brodie B, Stuckey T, Muncy D, Hansen C, Wall T, Pulsipher M . Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention. Am Heart J. 2003; 145(4):708-15. DOI: 10.1067/mhj.2003.9. View

Bavry A, Kumbhani D, Rassi A, Bhatt D, Askari A . Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol. 2006; 48(7):1319-25. DOI: 10.1016/j.jacc.2006.06.050. View

Armstrong P, Fu Y, Chang W, Topol E, Granger C, Betriu A . Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators. Circulation. 1998; 98(18):1860-8. DOI: 10.1161/01.cir.98.18.1860. View

10.

Diderholm E, Andren B, Frostfeldt G, Genberg M, Jernberg T, Lagerqvist B . The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy. Am Heart J. 2002; 143(5):760-7. DOI: 10.1067/mhj.2002.121733. View

11.

Hochman J, Lamas G, Buller C, Dzavik V, Reynolds H, Abramsky S . Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006; 355(23):2395-407. PMC: 1995554. DOI: 10.1056/NEJMoa066139. View

12.

Cannon C, Braunwald E, McCabe C, Rader D, Rouleau J, Belder R . Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004; 350(15):1495-504. DOI: 10.1056/NEJMoa040583. View

13.

de Araujo Goncalves P, Ferreira J, Aguiar C, Seabra-Gomes R . TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J. 2005; 26(9):865-72. DOI: 10.1093/eurheartj/ehi187. View

14.

Katritsis D, Ioannidis J . Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation. 2005; 111(22):2906-12. DOI: 10.1161/CIRCULATIONAHA.104.521864. View

15.

Ahmed S, Antman E, Murphy S, Giugliano R, Cannon C, White H . Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials). J Thromb Thrombolysis. 2006; 21(2):119-29. DOI: 10.1007/s11239-006-5485-9. View

16.

Nallamothu B, Bates E, Herrin J, Wang Y, Bradley E, Krumholz H . Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation. 2005; 111(6):761-7. DOI: 10.1161/01.CIR.0000155258.44268.F8. View

17.

McNamara R, Wang Y, Herrin J, Curtis J, Bradley E, Magid D . Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2006; 47(11):2180-6. DOI: 10.1016/j.jacc.2005.12.072. View

18.

Brodie B, Stuckey T, Wall T, Kissling G, Hansen C, Muncy D . Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 1998; 32(5):1312-9. DOI: 10.1016/s0735-1097(98)00395-7. View

19.

Hueb W, Soares P, Gersh B, Cesar L, Luz P, Puig L . The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol. 2004; 43(10):1743-51. DOI: 10.1016/j.jacc.2003.08.065. View

20.

Cannon C, Gibson C, LAMBREW C, Shoultz D, Levy D, French W . Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000; 283(22):2941-7. DOI: 10.1001/jama.283.22.2941. View